Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

How useful is 'burden of disease' to set public health priorities for infectious diseases?

Berkelman R, LeDuc J.

J Public Health Policy. 2015 Apr 30. doi: 10.1057/jphp.2015.15. [Epub ahead of print]

PMID:
25925086
2.

Adapting high-throughput screening methods and assays for biocontainment laboratories.

Rasmussen L, Tigabu B, White EL, Bostwick R, Tower N, Bukreyev A, Rockx B, LeDuc JW, Noah JW.

Assay Drug Dev Technol. 2015 Jan-Feb;13(1):44-54. doi: 10.1089/adt.2014.617.

PMID:
25710545
3.

Transmission of Ebola viruses: what we know and what we do not know.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Formenty P, Sanders DA, Kobinger GP.

MBio. 2015 Feb 19;6(2):e00137. doi: 10.1128/mBio.00137-15.

4.

Synthesis of air-stable, volatile uranium(IV) and (VI) compounds and their gas-phase conversion to uranium oxide films.

Appel L, Leduc J, Webster CL, Ziller JW, Evans WJ, Mathur S.

Angew Chem Int Ed Engl. 2015 Feb 9;54(7):2209-13. doi: 10.1002/anie.201409606. Epub 2014 Dec 23.

PMID:
25537920
5.

Environmental dependency of amphibian-ranavirus genotypic interactions: evolutionary perspectives on infectious diseases.

Echaubard P, Leduc J, Pauli B, Chinchar VG, Robert J, Lesbarrères D.

Evol Appl. 2014 Aug;7(7):723-33. doi: 10.1111/eva.12169. Epub 2014 Jun 16.

6.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.

PMID:
24895454
7.

Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013.

Gaudreau C, Barkati S, Leduc JM, Pilon PA, Favreau J, Bekal S.

Emerg Infect Dis. 2014 May;20(5):854-6. doi: 10.3201/eid2005.130966.

8.

A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus.

Tigabu B, Rasmussen L, White EL, Tower N, Saeed M, Bukreyev A, Rockx B, LeDuc JW, Noah JW.

Assay Drug Dev Technol. 2014 Apr;12(3):155-61. doi: 10.1089/adt.2013.567.

9.

Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Massey S, Yeager LA, Blumentritt CA, Vijayakumar S, Sbrana E, Peterson JW, Brasel T, LeDuc JW, Endsley JJ, Torres AG.

Sci Rep. 2014 Mar 7;4:4305. doi: 10.1038/srep04305.

10.

Oral apixaban for the treatment of acute venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators.

N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1.

11.

Apixaban for extended treatment of venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; PLIFY-EXT Investigators.

N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8.

12.

Synthesis and insertion chemistry of mixed tether uranium metallocene complexes.

Siladke NA, LeDuc J, Ziller JW, Evans WJ.

Chemistry. 2012 Nov 12;18(46):14820-7. doi: 10.1002/chem.201201908. Epub 2012 Oct 9.

PMID:
23047764
13.

Mycobacterium celatum skin infection with sporotrichoid spread in an HIV-negative immunocompromised man.

Leduc JM, Dufresne SF, Lavallée C, Nigen S, Labbé AC, Poirier L.

J Am Acad Dermatol. 2012 Jun;66(6):e247-9. doi: 10.1016/j.jaad.2011.06.034. No abstract available.

PMID:
22583731
14.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
15.

Recommendations for publication of viral genetic data and sample access for novel viruses and strains.

Arrigo NC, Briese T, Calisher CH, Drebot MA, Hjelle B, LeDuc JW, Powers AM, Repik PM, Roehrig JT, Schmaljohn CS, Tesh RB, Weaver SC.

Am J Trop Med Hyg. 2012 Feb;86(2):189-91. doi: 10.4269/ajtmh.2012.11-0523. No abstract available.

16.

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.

Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI; ADOPT Trial Investigators.

N Engl J Med. 2011 Dec 8;365(23):2167-77. doi: 10.1056/NEJMoa1110899. Epub 2011 Nov 13.

17.

[Visual impairment in elderly fallers].

Tran TH, Nguyen Van Nuoi D, Baiz H, Baglin G, Leduc JJ, Bulkaen H.

J Fr Ophtalmol. 2011 Dec;34(10):723-8. doi: 10.1016/j.jfo.2011.04.014. Epub 2011 Oct 11. French.

18.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

19.

Balancing our approach to the insider threat.

Franz DR, LeDuc JW.

Biosecur Bioterror. 2011 Sep;9(3):205-6. doi: 10.1089/bsp.2011.0052. Epub 2011 Aug 5. No abstract available.

PMID:
21819224
20.

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Nicol P, Vicaut E, Turpie AG, Yusen RD; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study.

Ann Intern Med. 2010 Jul 6;153(1):8-18. doi: 10.7326/0003-4819-153-1-201007060-00004.

PMID:
20621900
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk